Pharmacological perturbation of murine melanoma growth by copper chelates
- 17 March 1985
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 26 (2) , 221-233
- https://doi.org/10.1016/0304-3835(85)90030-8
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Combined modality of 2-formylpyridine monothiosemicarbazonato copper(II) and radiationInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Serum copper and zinc levels in melanoma patientsCancer, 1981
- Degradation of DNA by 1,-10-phenanthrolineBiochemical and Biophysical Research Communications, 1980
- In vivo inhibition of the tyrosinase of hamster melanoma with sodium diethyldithiocarbamateCellular and Molecular Life Sciences, 1979
- 1,10-Phenanthroline-cuprous ion complex, a potent inhibitor of DNA and RNA polymerasesBiochemical and Biophysical Research Communications, 1978
- The Biology of Cancer Invasion and MetastasisPublished by Elsevier ,1978
- Hypothesis for the Mechanism of Elevated Serum Copper in Cancer PatientsOncology, 1978
- Action of 1,10-phenanthroline transition metal chelates and their constituents on the rat isolated diaphragm preparationChemico-Biological Interactions, 1977
- The effect of copper on membrane enzymesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1970
- THE ACTION OF PHENYLTHIOCARBAMIDE ON TYROSINASEPublished by Elsevier ,1942